Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017535 · ClinicalTrials.gov registry record · Phase 1
An Adaptive Treatment Strategy for Adolescent Depression-Continuation
A Phase 1 study of Adolescent Depression, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02017535: Completed Phase 1 study of Adolescent Depression, sponsored by University of Minnesota.
NCT02017535 is a Phase 1 study of Adolescent Depression that has completed, run by University of Minnesota. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02017535, a Phase 1 study of Adolescent Depression, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy. Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment. Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personalized continuation treatment strategy to be tested in a subsequent R01 proposal.
Primary Outcome
The CDRS-R is a clinician-administered semi-structured interview designed to assess present episode and lifetime history of psychiatric diagnoses based on DSM-IV criteria. This survey contains 17 items; 3 items are rated on a scale from 0 to 5, 5 items are rated on a scale from 0 to 6, and the remaining 9 items are rated on a scale from 0 to 7. Total score is a raw sum of the 17 item scores and ranges from 0 to 108. Higher scores indicate greater depression severity.
Conditions Studied
Interventions
- BEHAVIORAL Interpersonal Psychotherapy
- DRUG Fluoxetine
Study Locations (1)
Minnesota
- University of Minnesota, Department of Psychiatry - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-10-01 |
| Phase | Phase 1 |
What the finished NCT02017535 record still lists
NCT02017535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Adolescent Depression appearing as the primary indexed condition, and to 2 interventions - of which Interpersonal Psychotherapy is the first listed.
NCT02017535 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02017535 about?
NCT02017535 is a clinical study titled "An Adaptive Treatment Strategy for Adolescent Depression-Continuation". Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy. Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment. Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personali...
What is the current status of trial NCT02017535?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-06. Estimated completion is 2018-10-01.
What conditions does trial NCT02017535 study?
This clinical trial studies the following conditions: Adolescent Depression.
What interventions are being tested in trial NCT02017535?
The interventions under investigation include: Interpersonal Psychotherapy (BEHAVIORAL), Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT02017535?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02017535 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adolescent Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02017535's enrollment target sits among peer trials
15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia